LIVN vs NVS
LivaNova vs Novartis AG — AI-powered side-by-side comparison
| Metric | LIVN | NVS |
|---|---|---|
| AI Score | 70 | 71 |
| Price | $78.12 | $154.44 |
| P/E Ratio | 22.65× | 23.58× |
| ROE | -20.2% | 30.5% |
| Revenue Growth YoY | — | — |
| Gross Margin | 68.2% | 74.3% |
| Debt / Equity | 0.27× | 1.18× |
| Dividend Yield | 0.0% | 2.9% |
| RSI (14) | 40.2 | 46.9 |
| Beta | 0.862 | 0.46 |
| Expected Upside | +4.6% | +1.2% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
LIVN Full Analysis
NVS Full Analysis